Chronic kidney disease trials recruiting in Illinois

All Chronic kidney disease trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
  NCT06830629 · Phase: Phase 2 · Ages: 18 Years to 68 Years · Sex: All (male and female) · Illinois: Chicago, Evanston
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Champaign, Maywood, Rockford
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
  NCT07662135 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
  NCT07222917 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Champaign
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Skokie
• A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
  NCT07268638 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
  NCT06749457 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Illinois: Chicago
• A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
  NCT07107945 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Illinois: Chicago
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Champaign, Chicago, Rockford, Tinley Park
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
  NCT07024823 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
  NCT06754280 · Phase: Not applicable (e.g. observational or device study) · Ages: 35 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago
• An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
  NCT05106387 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · Illinois: Chicago
• Breakthrough - T1DM and Chronic Kidney Disease
  NCT07592000 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Illinois: Chicago
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · Illinois: Alton, Aurora, Barrington, Bloomington
• Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
  NCT03803423 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Empagliflozin Treatment in Kidney Transplant Recipients
  NCT06013865 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · Illinois: Hines
• Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
  NCT06374537 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease
  NCT06430684 · Phase: Early Phase 1 · Ages: 12 Years to 25 Years · Sex: All (male and female) · Illinois: Chicago
• Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
  NCT06397456 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · Illinois: Chicago
• Interactive Computer-adaptive Chronic Kidney Disease Education Program
  NCT06364358 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · Illinois: Chicago
• Kidney Precision Medicine Project
  NCT04334707 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
  NCT06190717 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 84 Years · Sex: All (male and female) · Illinois: Chicago
• Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
  NCT01531257 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
  NCT01644903 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• REgulatory T Cell Therapy to Achieve Immunosuppression REduction
  NCT06552169 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Illinois: Chicago
• Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
  NCT07059962 · Phase: Not specified · Ages: 21 Years and older · Sex: All (male and female) · Illinois: Chicago
• Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
  NCT06217302 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• Study of BHV-1400 in IgA Nephropathy
  NCT07054684 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Illinois: Hinsdale
• Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
  NCT07271186 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago
• Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
  NCT06878560 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 70 Years · Sex: All (male and female) · Illinois: Chicago
• Transformative Research in Diabetic Nephropathy
  NCT02986984 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Illinois: Chicago